drugset / Trial / NCT01061320
Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to demonstrate the efficacy of alpha tocopherol for prevention contrast-induced nephropathy in CKD patients undergoing elective coronary procedures.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-10
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | alpha-tocopherol | Unknown | 525 iu | Oral |